Bicycle Therapeutics plc
BCYC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $536 | $481 | $587 | $967 |
| - Cash | $648 | $721 | $793 | $880 |
| + Debt | $1 | $7 | $8 | $9 |
| Enterprise Value | -$111 | -$233 | -$197 | $97 |
| Revenue | $12 | $3 | $10 | $4 |
| % Growth | 301.8% | -70.7% | 169.1% | – |
| Gross Profit | $12 | -$68 | -$47 | -$52 |
| % Margin | 100% | -2,332.5% | -474% | -1,412.2% |
| EBITDA | -$57 | -$77 | -$70 | -$66 |
| % Margin | -486.6% | -2,651.8% | -703.7% | -1,778.8% |
| Net Income | -$59 | -$79 | -$61 | -$52 |
| % Margin | -503.7% | -2,703.8% | -608.9% | -1,398.4% |
| EPS Diluted | -0.85 | -1.14 | -0.88 | -0.74 |
| % Growth | 25.4% | -29.5% | -18.9% | – |
| Operating Cash Flow | -$71 | -$73 | -$87 | -$9 |
| Capital Expenditures | -$1 | -$0 | -$1 | -$0 |
| Free Cash Flow | -$72 | -$73 | -$87 | -$10 |